Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 12 results.
User Information
Export Records
  1. 1.   Leveraging long-acting IL-15 agonists for intratumoral delivery and enhanced antimetastatic activity
  2. Hangasky, John A; Fernández, Rocío Del Valle; Stellas,Dimitris; Hails, Guillermo; Karaliota,Sevasti; Ashley, Gary W; Felber,Barbara; Pavlakis,George; Santi, Daniel V
  3. Frontiers in Immunology. 2024, Nov 4; 15: 1458145.
  1. 2.   Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
  2. Stevens, David M.; Crist,Rachael; Stern,Steve
  3. Molecules (Basel, Switzerland). 2021, Jan; 26(1):
  1. 3.   Characterization of Recombinant Human IL-15 Deamidation and Its Practical Elimination through Substitution of Asparagine 77
  2. Nellis, D. F.; Michiel, D. F.; Jiang, M. S.; Esposito, D.; Davis, R.; Jiang, H. G.; Korrell, A.; Knapp, G. C.; Lucernoni, L. E.; Nelson, R. E.; Pritt, E. M.; Procter, L. V.; Rogers, M.; Sumpter, T. L.; Vyas, V. V.; Waybright, T. J.; Yang, X. Y.; Zheng, A. M.; Yovandich, J. L.; Gilly, J. A.; Mitra, G.; Zhu, J. W.
  3. Pharmaceutical Research. 2012, Mar; 29(3): 722-738.
  1. 4.   Synergistic Interaction of the Triple Combination of Amphotericin B, Ciprofloxacin, and Polymorphonuclear Neutrophils against Aspergillus fumigatus
  2. Stergiopoulou, T.; Meletiadis, J.; Sein, T.; Papaioannidou, P.; Walsh, T. J.; Roilides, E.
  3. Antimicrobial Agents and Chemotherapy. 2011, Dec; 55(12): 5923-5929.
  1. 5.   Chromatographic methods for the quantification of free and chelated gadolinium species in MRI contrast agent formulations
  2. Clevel, D.; Long, S. E.; Sander, L. C.; Davis, W. C.; Murphy, K. E.; Case, R. J.; Rimmer, C. A.; Francini, L.; Patri, A. K.
  3. Analytical and Bioanalytical Chemistry. 2010, Dec; 398(7-8): 2987-2995.
  1. 6.   The Initial 96 Hours of Invasive Pulmonary Aspergillosis: Histopathology, Comparative Kinetics of Galactomannan and (1 -> 3)-beta-D-Glucan, and Consequences of Delayed Antifungal Therapy
  2. Hope, W. W.; Petraitis, V.; Petraitiene, R.; Aghamolla, T.; Bacher, J.; Walsh, T. J.
  3. Antimicrobial Agents and Chemotherapy. 2010, Nov; 54(11): 4879-4886.
  1. 7.   Stabilization of the Nitric Oxide (NO) Prodrugs and Anticancer Leads, PABA/NO and Double JS-K, through Incorporation into PEG-Protected Nanoparticles
  2. Kumar, V.; Hong, S. Y.; Maciag, A. E.; Saavedra, J. E.; Adamson, D. H.; Prud'homme, R. K.; Keefer, L. K.; Chakrapani, H.
  3. Molecular Pharmaceutics. 2010, Jan-Feb; 7(1): 291-298.
  1. 8.   Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatment
  2. Gardner, E. R.; Dahut, W.; Figg, W. D.
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2008 862(1-2): 213-218.
  1. 9.   Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel
  2. Gardner, E. R.; Dahut, W. L.; Scripture, C. D.; Jones, J.; Aragon-Ching, J. B.; Desai, N.; Hawkins, M. J.; Sparreboom, A.; Figg, W. D.
  3. Clinical Cancer Research. 2008 14(13): 4200-4205.
  1. 10.   Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis
  2. Petraitis, V.; Petraitiene, R.; Lin, P. X.; Calis, K.; Kelaher, A. M.; Muray, H. A.; Mya-San, C.; Mickiene, D.; Bacher, J.; Walsh, T. J.
  3. Antimicrobial Agents and Chemotherapy. 2005 49(4): 1642-1645.
  1. 11.   Designing an In Vivo Efficacy Study of Nanomedicines for Preclinical Tumor Growth Inhibition
  2. Adiseshaiah, Pavan; Stern, Steve
  3. Methods in molecular biology (Clifton, N.J.). 2018 1682: 241-253.
  1. 12.   Measuring Size and Number Concentration of Metallic Nanoparticles Using spICP-MS
  2. Hansen,Matthew; Clogston,Jeffrey
  3. Methods in Molecular Biology (Clifton, N.J.). 2024 2789: 53-66.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel